San Diego’s Ligand Takes Advantage of the Great Recession to Build New Drug Pipeline

Diego biotech that went public in 1992. During the 15 years that followed its IPO, Ligand brought five drugs to market, reported 2005 sales of more than $ 176 million, and once employed 650 people. The same company posted annual revenue of just $ 23.5
Moreover Technologies – Search results for… drugs – 30 of 1143 returned

Leave a Reply